[PDF][PDF] CXCL10 impairs β cell function and viability in diabetes through TLR4 signaling

FT Schulthess, F Paroni, NS Sauter, L Shu, P Ribaux… - Cell metabolism, 2009 - cell.com
FT Schulthess, F Paroni, NS Sauter, L Shu, P Ribaux, L Haataja, RM Strieter, J Oberholzer…
Cell metabolism, 2009cell.com
In type 1 and type 2 diabetes (T1/T2DM), β cell destruction by apoptosis results in decreased
β cell mass and progression of the disease. In this study, we found that the interferon γ-
inducible protein 10 plays an important role in triggering β cell destruction. Islets isolated
from patients with T2DM secreted CXCL10 and contained 33.5-fold more CXCL10 mRNA
than islets from control patients. Pancreatic sections from obese nondiabetic individuals and
patients with T2DM and T1DM expressed CXCL10 in β cells. Treatment of human islets with …
Summary
In type 1 and type 2 diabetes (T1/T2DM), β cell destruction by apoptosis results in decreased β cell mass and progression of the disease. In this study, we found that the interferon γ-inducible protein 10 plays an important role in triggering β cell destruction. Islets isolated from patients with T2DM secreted CXCL10 and contained 33.5-fold more CXCL10 mRNA than islets from control patients. Pancreatic sections from obese nondiabetic individuals and patients with T2DM and T1DM expressed CXCL10 in β cells.
Treatment of human islets with CXCL10 decreased β cell viability, impaired insulin secretion, and decreased insulin mRNA. CXCL10 induced sustained activation of Akt, JNK, and cleavage of p21-activated protein kinase 2 (PAK-2), switching Akt signals from proliferation to apoptosis. These effects were not mediated by the commonly known CXCL10 receptor CXCR3 but through TLR4. Our data suggest CXCL10 as a binding partner for TLR4 and as a signal toward β cell failure in diabetes.
cell.com